Effect of Apple and Apple Pomace on Inflammation and Cholesterol Metabolism in Healthy Overweight

July 19, 2016 updated by: Arne Astrup, University of Copenhagen

Isafruit: Nutrigenomics in Overweight

The investigators will assess the protective and antiinflammatory effects of processed fruit and fruit fibre in overweight subjects with signs of metabolic syndrome. A single-blinded parallel study is conducted to investigate the protective effects of fruit fibre on colonic epithelium. Relevant signalling pathways related to cholesterol metabolism, vascular inflammation, oxidative defence, apoptosis and sterol metabolism will be targeted. Volunteers are randomly assigned one of three groups. They are instructed to follow a polyphenol and pectin restricted diet for six weeks. The last four weeks in this six week period, the restricted diet is supplemented with whole apples (550g/day), apple pomace (22g/day) or nothing. Blood, urine, faecal samples and colon biopsies are collected before and after the four weeks intervention period.

Study Overview

Study Type

Interventional

Enrollment (Actual)

37

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Frederiksberg, Denmark, 1951
        • Department of Human Nutrition, Life, University of Copenhagen

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Healthy
  • BMI over 30
  • No daily medication
  • Not strenuous exercise > 10hours/week
  • No blood donation 3 months before or during the study

Exclusion Criteria:

  • Smoking
  • Simultaneous participation in other research projects
  • Use of any dietary supplements

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: control
Active Comparator: Apples
550g of apples/day
Active Comparator: Apple pomace
22g apple pomace/day

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Blood lipid profile (triacylglycerol and total-, LDL- and HDL-cholesterol)
Time Frame: Measured at week 2
Measured at week 2
Blood lipid profile (triacylglycerol and total-, LDL- and HDL-cholesterol)
Time Frame: Measured at week 6
Measured at week 6

Secondary Outcome Measures

Outcome Measure
Time Frame
Blood pressure
Time Frame: Measured at week 2
Measured at week 2
Blood pressure
Time Frame: Measured at week 6
Measured at week 6
Anthropometry (weight, height, waist and hip circumference)
Time Frame: Measured at week 2
Measured at week 2
Anthropometry (weight, height, waist and hip circumference)
Time Frame: Measured at week 6
Measured at week 6
Inflammatory marker (hs-CRP)
Time Frame: Measured at week 2
Measured at week 2
Inflammatory marker (hs-CRP)
Time Frame: Measured at week 6
Measured at week 6
Faeces analyses (metabolomics, pH, bile acids, short-chain fatty acids)
Time Frame: Measured at week 2
Measured at week 2
Faeces analyses (metabolomics, pH, bile acids, short-chain fatty acids)
Time Frame: Measured at week 6
Measured at week 6
Urine analyses (metabolomics)
Time Frame: Measured at week 2
Measured at week 2
Urine analyses (metabolomics)
Time Frame: Measured at week 6
Measured at week 6
Serum insulin, IGF-1 and IGFBP-3 levels
Time Frame: Measured at week 2
Measured at week 2
Serum insulin, IGF-1 and IGFBP-3 levels
Time Frame: Measured at week 6
Measured at week 6
Gene expression in white blood cells and colon tissue
Time Frame: Measured at week 2
Measured at week 2
Gene expression in white blood cells and colon tissue
Time Frame: Measured at week 6
Measured at week 6
Enzyme activity in lysed erythrocytes (glutathione peroxidase)
Time Frame: Measured at week 2
Measured at week 2
Enzyme activity in lysed erythrocytes (glutathione peroxidase)
Time Frame: Measured at week 6
Measured at week 6

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Susanne Bügel, PhD, Department of Human Nutrition, LIFE, University of Copenhagen, Denmark

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2008

Primary Completion (Actual)

December 1, 2009

Study Completion (Actual)

October 1, 2010

Study Registration Dates

First Submitted

June 8, 2010

First Submitted That Met QC Criteria

June 10, 2010

First Posted (Estimate)

June 11, 2010

Study Record Updates

Last Update Posted (Estimate)

July 20, 2016

Last Update Submitted That Met QC Criteria

July 19, 2016

Last Verified

July 1, 2016

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Diseases

Clinical Trials on Apples

3
Subscribe